Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nasal Sevoflurane vs. IV Ketamine, Midazolam, and Propofol for Pediatric GI Endoscopy
NCT05474937Unknown
- Sponsor
- Zagazig University
- Start
- Jun 2022
- Primary completion
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of sevoflurane in upper gastrointestinal bleeding (UGIB) (2 arms), sponsored by Zagazig University. Primary endpoint: Modified Ramsay Sedation Score at 1 hour. Status: unknown.
02
Drugs
sevoflurane
03
Conditions
upper gastrointestinal bleeding (UGIB)
Beyond the preview
Go deeper on NCT05474937.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05474937.